{
  "id": 15024110,
  "title": "First At-Home Thyroid Eye Disease Shot Approved",
  "url": "https://urgent.news/2026/10/16/first-at-home-thyroid-eye-disease-shot-approved",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-16T18:34:47.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/endocrinology/thyroid/123453"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- The FDA approved satralizumab (Enspryng), the first and only at-home subcutaneous treatment option for adults with thyroid eye disease (TED), developer Roche announced on Thursday. The first-in-class drug is a humanized monoclonal...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}